Global Leukemia Cancer Market Research Report 2023

Report ID: 1991667 | Published Date: Oct 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leukemia Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Radiation Therapy
        1.2.4 Targeted Therapy
        1.2.5 Biological Therapy
        1.2.6 Stem Cell Transplant
    1.3 Market by Application
        1.3.1 Global Leukemia Cancer Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Acute Myeloid Leukaemia (AML)
        1.3.3 Chronic Myeloid Leukaemia (CML)
        1.3.4 Acute Lymphoblastic Leukaemia (ALL)
        1.3.5 Chronic Lymphocytic Leukaemia (CLL)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Leukemia Cancer Market Perspective (2017-2028)
    2.2 Leukemia Cancer Growth Trends by Region
        2.2.1 Leukemia Cancer Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Leukemia Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Leukemia Cancer Forecasted Market Size by Region (2023-2028)
    2.3 Leukemia Cancer Market Dynamics
        2.3.1 Leukemia Cancer Industry Trends
        2.3.2 Leukemia Cancer Market Drivers
        2.3.3 Leukemia Cancer Market Challenges
        2.3.4 Leukemia Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leukemia Cancer Players by Revenue
        3.1.1 Global Top Leukemia Cancer Players by Revenue (2017-2022)
        3.1.2 Global Leukemia Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Leukemia Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leukemia Cancer Revenue
    3.4 Global Leukemia Cancer Market Concentration Ratio
        3.4.1 Global Leukemia Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leukemia Cancer Revenue in 2021
    3.5 Leukemia Cancer Key Players Head office and Area Served
    3.6 Key Players Leukemia Cancer Product Solution and Service
    3.7 Date of Enter into Leukemia Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Cancer Breakdown Data by Type
    4.1 Global Leukemia Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Leukemia Cancer Forecasted Market Size by Type (2023-2028)
5 Leukemia Cancer Breakdown Data by Application
    5.1 Global Leukemia Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Leukemia Cancer Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Leukemia Cancer Market Size (2017-2028)
    6.2 North America Leukemia Cancer Market Size by Country (2017-2022)
    6.3 North America Leukemia Cancer Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Leukemia Cancer Market Size (2017-2028)
    7.2 Europe Leukemia Cancer Market Size by Country (2017-2022)
    7.3 Europe Leukemia Cancer Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leukemia Cancer Market Size (2017-2028)
    8.2 Asia-Pacific Leukemia Cancer Market Size by Country (2017-2022)
    8.3 Asia-Pacific Leukemia Cancer Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Leukemia Cancer Market Size (2017-2028)
    9.2 Latin America Leukemia Cancer Market Size by Country (2017-2022)
    9.3 Latin America Leukemia Cancer Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leukemia Cancer Market Size (2017-2028)
    10.2 Middle East & Africa Leukemia Cancer Market Size by Country (2017-2022)
    10.3 Middle East & Africa Leukemia Cancer Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Detail
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Leukemia Cancer Introduction
        11.1.4 Biogen Revenue in Leukemia Cancer Business (2017-2022)
        11.1.5 Biogen Recent Development
    11.2 GSK
        11.2.1 GSK Company Detail
        11.2.2 GSK Business Overview
        11.2.3 GSK Leukemia Cancer Introduction
        11.2.4 GSK Revenue in Leukemia Cancer Business (2017-2022)
        11.2.5 GSK Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Leukemia Cancer Introduction
        11.3.4 Novartis Revenue in Leukemia Cancer Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Leukemia Cancer Introduction
        11.4.4 Pfizer Revenue in Leukemia Cancer Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Leukemia Cancer Introduction
        11.5.4 Roche Revenue in Leukemia Cancer Business (2017-2022)
        11.5.5 Roche Recent Development
    11.6 Takeda Oncology
        11.6.1 Takeda Oncology Company Detail
        11.6.2 Takeda Oncology Business Overview
        11.6.3 Takeda Oncology Leukemia Cancer Introduction
        11.6.4 Takeda Oncology Revenue in Leukemia Cancer Business (2017-2022)
        11.6.5 Takeda Oncology Recent Development
    11.7 Teva Pharmaceutical
        11.7.1 Teva Pharmaceutical Company Detail
        11.7.2 Teva Pharmaceutical Business Overview
        11.7.3 Teva Pharmaceutical Leukemia Cancer Introduction
        11.7.4 Teva Pharmaceutical Revenue in Leukemia Cancer Business (2017-2022)
        11.7.5 Teva Pharmaceutical Recent Development
    11.8 Celgene
        11.8.1 Celgene Company Detail
        11.8.2 Celgene Business Overview
        11.8.3 Celgene Leukemia Cancer Introduction
        11.8.4 Celgene Revenue in Leukemia Cancer Business (2017-2022)
        11.8.5 Celgene Recent Development
    11.9 Daiichi Sankyo
        11.9.1 Daiichi Sankyo Company Detail
        11.9.2 Daiichi Sankyo Business Overview
        11.9.3 Daiichi Sankyo Leukemia Cancer Introduction
        11.9.4 Daiichi Sankyo Revenue in Leukemia Cancer Business (2017-2022)
        11.9.5 Daiichi Sankyo Recent Development
    11.10 EISAI
        11.10.1 EISAI Company Detail
        11.10.2 EISAI Business Overview
        11.10.3 EISAI Leukemia Cancer Introduction
        11.10.4 EISAI Revenue in Leukemia Cancer Business (2017-2022)
        11.10.5 EISAI Recent Development
    11.11 Sunesis Pharmaceuticals
        11.11.1 Sunesis Pharmaceuticals Company Detail
        11.11.2 Sunesis Pharmaceuticals Business Overview
        11.11.3 Sunesis Pharmaceuticals Leukemia Cancer Introduction
        11.11.4 Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2017-2022)
        11.11.5 Sunesis Pharmaceuticals Recent Development
    11.12 Bristol-Myers Squibb
        11.12.1 Bristol-Myers Squibb Company Detail
        11.12.2 Bristol-Myers Squibb Business Overview
        11.12.3 Bristol-Myers Squibb Leukemia Cancer Introduction
        11.12.4 Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2017-2022)
        11.12.5 Bristol-Myers Squibb Recent Development
    11.13 Spectrum Pharmaceuticals
        11.13.1 Spectrum Pharmaceuticals Company Detail
        11.13.2 Spectrum Pharmaceuticals Business Overview
        11.13.3 Spectrum Pharmaceuticals Leukemia Cancer Introduction
        11.13.4 Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2017-2022)
        11.13.5 Spectrum Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Leukemia Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Radiation Therapy
    Table 4. Key Players of Targeted Therapy
    Table 5. Key Players of Biological Therapy
    Table 6. Key Players of Stem Cell Transplant
    Table 7. Global Leukemia Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Leukemia Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Leukemia Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Leukemia Cancer Market Share by Region (2017-2022)
    Table 11. Global Leukemia Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Leukemia Cancer Market Share by Region (2023-2028)
    Table 13. Leukemia Cancer Market Trends
    Table 14. Leukemia Cancer Market Drivers
    Table 15. Leukemia Cancer Market Challenges
    Table 16. Leukemia Cancer Market Restraints
    Table 17. Global Leukemia Cancer Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Leukemia Cancer Market Share by Players (2017-2022)
    Table 19. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2021)
    Table 20. Ranking of Global Top Leukemia Cancer Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Leukemia Cancer Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Leukemia Cancer Product Solution and Service
    Table 24. Date of Enter into Leukemia Cancer Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Leukemia Cancer Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Leukemia Cancer Revenue Market Share by Type (2017-2022)
    Table 28. Global Leukemia Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Leukemia Cancer Revenue Market Share by Type (2023-2028)
    Table 30. Global Leukemia Cancer Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Leukemia Cancer Revenue Market Share by Application (2017-2022)
    Table 32. Global Leukemia Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Leukemia Cancer Revenue Market Share by Application (2023-2028)
    Table 34. North America Leukemia Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Leukemia Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Leukemia Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Leukemia Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Leukemia Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Leukemia Cancer Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Leukemia Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Leukemia Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Leukemia Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Leukemia Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Biogen Company Detail
    Table 45. Biogen Business Overview
    Table 46. Biogen Leukemia Cancer Product
    Table 47. Biogen Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 48. Biogen Recent Development
    Table 49. GSK Company Detail
    Table 50. GSK Business Overview
    Table 51. GSK Leukemia Cancer Product
    Table 52. GSK Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 53. GSK Recent Development
    Table 54. Novartis Company Detail
    Table 55. Novartis Business Overview
    Table 56. Novartis Leukemia Cancer Product
    Table 57. Novartis Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 58. Novartis Recent Development
    Table 59. Pfizer Company Detail
    Table 60. Pfizer Business Overview
    Table 61. Pfizer Leukemia Cancer Product
    Table 62. Pfizer Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 63. Pfizer Recent Development
    Table 64. Roche Company Detail
    Table 65. Roche Business Overview
    Table 66. Roche Leukemia Cancer Product
    Table 67. Roche Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Takeda Oncology Company Detail
    Table 70. Takeda Oncology Business Overview
    Table 71. Takeda Oncology Leukemia Cancer Product
    Table 72. Takeda Oncology Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 73. Takeda Oncology Recent Development
    Table 74. Teva Pharmaceutical Company Detail
    Table 75. Teva Pharmaceutical Business Overview
    Table 76. Teva Pharmaceutical Leukemia Cancer Product
    Table 77. Teva Pharmaceutical Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 78. Teva Pharmaceutical Recent Development
    Table 79. Celgene Company Detail
    Table 80. Celgene Business Overview
    Table 81. Celgene Leukemia Cancer Product
    Table 82. Celgene Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 83. Celgene Recent Development
    Table 84. Daiichi Sankyo Company Detail
    Table 85. Daiichi Sankyo Business Overview
    Table 86. Daiichi Sankyo Leukemia Cancer Product
    Table 87. Daiichi Sankyo Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 88. Daiichi Sankyo Recent Development
    Table 89. EISAI Company Detail
    Table 90. EISAI Business Overview
    Table 91. EISAI Leukemia Cancer Product
    Table 92. EISAI Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 93. EISAI Recent Development
    Table 94. Sunesis Pharmaceuticals Company Detail
    Table 95. Sunesis Pharmaceuticals Business Overview
    Table 96. Sunesis Pharmaceuticals Leukemia CancerProduct
    Table 97. Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 98. Sunesis Pharmaceuticals Recent Development
    Table 99. Bristol-Myers Squibb Company Detail
    Table 100. Bristol-Myers Squibb Business Overview
    Table 101. Bristol-Myers Squibb Leukemia CancerProduct
    Table 102. Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 103. Bristol-Myers Squibb Recent Development
    Table 104. Spectrum Pharmaceuticals Company Detail
    Table 105. Spectrum Pharmaceuticals Business Overview
    Table 106. Spectrum Pharmaceuticals Leukemia CancerProduct
    Table 107. Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2017-2022) & (US$ Million)
    Table 108. Spectrum Pharmaceuticals Recent Development
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leukemia Cancer Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Radiation Therapy Features
    Figure 4. Targeted Therapy Features
    Figure 5. Biological Therapy Features
    Figure 6. Stem Cell Transplant Features
    Figure 7. Global Leukemia Cancer Market Share by Application in 2021 & 2028
    Figure 8. Acute Myeloid Leukaemia (AML) Case Studies
    Figure 9. Chronic Myeloid Leukaemia (CML) Case Studies
    Figure 10. Acute Lymphoblastic Leukaemia (ALL) Case Studies
    Figure 11. Chronic Lymphocytic Leukaemia (CLL) Case Studies
    Figure 12. Leukemia Cancer Report Years Considered
    Figure 13. Global Leukemia Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Leukemia Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Leukemia Cancer Market Share by Region: 2021 VS 2028
    Figure 16. Global Leukemia Cancer Market Share by Players in 2021
    Figure 17. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Leukemia Cancer Revenue in 2021
    Figure 19. North America Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Leukemia Cancer Market Share by Country (2017-2028)
    Figure 21. United States Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Leukemia Cancer Market Share by Country (2017-2028)
    Figure 25. Germany Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Leukemia Cancer Market Share by Region (2017-2028)
    Figure 33. China Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Leukemia Cancer Market Share by Country (2017-2028)
    Figure 41. Mexico Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Leukemia Cancer Market Share by Country (2017-2028)
    Figure 45. Turkey Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Leukemia Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Biogen Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 48. GSK Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 51. Roche Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 52. Takeda Oncology Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 53. Teva Pharmaceutical Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 54. Celgene Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 55. Daiichi Sankyo Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 56. EISAI Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 57. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 59. Spectrum Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
GSK
Novartis
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI
Sunesis Pharmaceuticals
Bristol-Myers Squibb
Spectrum Pharmaceuticals
Frequently Asked Questions
Leukemia Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leukemia Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leukemia Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports